Royan Institute Researchers Make Molecule-Based Products to Diagnose Diseases

“Our company's products are research-based and are supplied to research centers and all universities. These products can be used for diagnosis and treatment of cancers and most diseases,” Saeed Mohebbi, the director of Research and Development (R&D) department of the technological company, told ANA.
“This product inhibits miRNA molecules and prevents the development of cancer cells. There are different types of microRNA products. Some of these products are microRNA themselves; with these molecules, we prevent gene expression to prevent cells from becoming sick,” he added.
“The next product in our company is siRNA. siRNA is also designed against a specific gene and works to inhibit gene expression; if the gene is pathogenic, we use these molecules to block the expression of that gene to prevent that cell from becoming sick,” Mohebbi noted.
“The diagnostic products of our company also include various types of probes and different forms of biomarkers. When a cell becomes cancerous, biomarkers in tumors (tumor markers) and biomarkers enter the bloodstream or body fluids like urine. Through these markers, it is determined whether a person has cancer or not,” he said.
In a relevant development in 2023, Iranian scientists at Royan Institute for Stem Cell Biology and Technology’s Cord Blood Bank had succeeded in production of wound dressings by using umbilical cord blood and amniotic membranes.
Iranian researchers and technologists at Royan Cord Blood Bank have managed to produce useful and valuable products like culture medium for stem cell proliferation and wound dressings by using biological waste from childbirth and umbilical cord blood in addition to storing 185,000 umbilical cord blood samples.
Royan Institute was established in 1991 by a group of researchers and physicians in Iran University of Medical Sciences of ACECR as an outpatient surgery center to provide medical services to infertile couples as well as research and training in reproductive sciences.
4155/v